Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, no par value
-
Total 13F shares
-
23,664,601
-
Share change
-
-1,077,087
-
Total reported value
-
$40,699,713
-
Put/Call ratio
-
15%
-
Price per share
-
$1.72
-
Number of holders
-
48
-
Value change
-
-$4,573,203
-
Number of buys
-
18
-
Number of sells
-
28
Institutional Holders of Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) as of Q4 2021
As of 31 Dec 2021 Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,664,601 shares of stock of the company.
Largest 10 holders included Slate Path Capital LP, MFN Partners Management, LP, Artal Group S.A., FMR LLC, VANGUARD GROUP INC, PURA VIDA INVESTMENTS, LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, Ikarian Capital, LLC, and BlackRock Inc..
This table shows 48 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.